Abstract:Objective: To develop an effective molecular approach by target gene capture and next generation sequencing for the diagnosis of metabolic myopathies. Background Metabolic myopathy is a group of clinically and genetically heterogeneous diseases due to defects in cellular energy metabolism, which includes three major categories: glycogen storage diseases, fatty acid oxidation, and mitochondrial respiratory chain disorders. Clinical presentation, abnormal metabolites, and biochemical enzymatic analyses may help with the diagnosis of the disease, however, the ultimate definitive diagnosis is the identification of causative molecular defects in the genes responsible for the disease. Design/Methods: A group of 24 nuclear genes commonly found to be associated with metabolic myopathies were enriched by hybridization of genome DNA with target gene specific probes (NimbleGen) followed by next generation sequencing (NGS). In addition, one single pair of primer was used to amplify the whole 16.6 kb mitochondrial genome (mtDNA) for massively parallel sequencing by NGS. Results: The sequencing was performed using Illumina9s HiSeq 2000. Twelve individually barcoded samples were pooled and analyzed. QC samples are indexed accordingly and spiked in with each sample. The coverage depth for the nuclear genes was 500X and for the mitochondrial genome was 20,000X. This deep coverage allows accurate base calls and quantitative analysis of mtDNA mutation heteroplasmy. Our results demonstrated that mutations in POLG, OPA1, LCHAD, CPTII, PHKs , and PYGM genes were all correctly identified. In addition, heteroplasmy of mtDNA point mutations and large deletion with breakpoints were also accurately determined. Conclusions: Capture of target genes in combination with long range PCR of mtDNA followed by next generation massively parallel sequencing allows cost effective analyses of a group of genes commonly involved in metabolic myopathies. This approach also provides quantitative information of mtDNA point mutations and large deletions. Disclosure: Dr. Zhang has nothing to disclose. Dr. Cui has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Wong has nothing to disclose.

Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Whole-Genome Sequencing in A Patient with Charcot-Marie-Tooth Neuropathy.

Mitochondrial cytochrome c oxidase deficiency.

Expression signature of the Leigh syndrome French-Canadian type

Expert panel curation of 113 primary mitochondrial disease genes for the Leigh syndrome spectrum

Untargeted proteomics enables ultra-rapid variant prioritization in mitochondrial and other rare diseases

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Molecular Diagnostic Approaches to Metabolic Myopathies by Target Gene Capture and Next Generation Sequencing (P07.215)

Mapping the proteo-genomic convergence of human diseases

Exome sequencing in undiagnosed congenital myopathy reveals new genes and refines genes-phenotypes correlations

Genetic heterogeneity in Leigh syndrome: Highlighting treatable and novel genetic causes

Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

A cryptic pathogenic NDUFV1 variant identified by RNA-seq in a patient with normal complex I activity in muscle and transient magnetic resonance imaging changes

A patient with homozygous nonsense variants in two Leigh syndrome disease genes: Distinguishing a dual diagnosis from a hypomorphic protein‐truncating variant

Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success

Comprehensive Detection of Genes Causing a Phenotype Using Phenotype Sequencing and Pathway Analysis

Prediction of Human Disease Genes by Human-Mouse Conserved Coexpression Analysis

Recent advances in understanding the molecular genetic basis of mitochondrial disease